Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Promising clinical trial results reported for Medeva's Hepagene as vaccine and treatment

Oct. 23, 1997

Axcan completes phase III trial for H. pylori eradication

Oct. 22, 1997

OraVax to develop new treatments for Clostridium difficile-associated disease

Oct. 22, 1997

Diagnon receives NCI grant for H. pylori research

Oct. 17, 1997

Fujisawa launches new OTC product

Oct. 17, 1997

Schering-Plough extends collaboration with Pharmacopeia to include hepatitis

Oct. 14, 1997

ImmuCell receives grant to develop TravelGAM

Oct. 10, 1997

CCK-A antagonists for the treatment of pancreatitis

Oct. 9, 1997

First approval for Infergen

Oct. 8, 1997

NTZ: a potential new anti-H. pylori agent

Oct. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...